03-06-2020, 3.5 Million Share Institutional Buy-In tells only a snippet of the overall story with this dream stock. sec.report To get the real grasp of what we have here, look to my previous post and take in this analogy as deeply as possible: In the Coronavirus Market: $COCP is to Treatment what $IBIO is to Vaccines or what $OPK is to Testing. $COCP has...
Alert set for breakout above $2.32 Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded on January...
Made a 37% move after hours Friday on the launch of COVID19 program Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections....
BOTHELL, WA,, March 06, 2020 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage Biotechnology company discovering and developing novel antiviral therapeutics, today announced it has initiated its Coronavirus program. finance.yahoo.com “Following our acquisition of patent rights and know-how from KSURF and...
Haven't read up on the company. Looks like a double bottom... but pharma is getting hit hard.... LABD looks super bullish